106 related articles for article (PubMed ID: 6501927)
1. Live attenuated influenza A virus vaccines in children: results of a field trial.
Belshe RB; Van Voris LP; Bartram J; Crookshanks FK
J Infect Dis; 1984 Dec; 150(6):834-40. PubMed ID: 6501927
[TBL] [Abstract][Full Text] [Related]
2. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge.
Belshe RB; Van Voris LP
J Infect Dis; 1984 May; 149(5):735-40. PubMed ID: 6726003
[TBL] [Abstract][Full Text] [Related]
3. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
[TBL] [Abstract][Full Text] [Related]
4. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
[TBL] [Abstract][Full Text] [Related]
5. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
[TBL] [Abstract][Full Text] [Related]
6. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.
Snyder MH; Clements ML; Betts RF; Dolin R; Buckler-White AJ; Tierney EL; Murphy BR
J Clin Microbiol; 1986 May; 23(5):852-7. PubMed ID: 3711273
[TBL] [Abstract][Full Text] [Related]
8. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
Gorse GJ; Belshe RB; Munn NJ
J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
[TBL] [Abstract][Full Text] [Related]
9. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
[TBL] [Abstract][Full Text] [Related]
10. Cold-adapted recombinant influenza A virus vaccines in seronegative young children.
Wright PF; Okabe N; McKee KT; Maassab HF; Karzon DT
J Infect Dis; 1982 Jul; 146(1):71-9. PubMed ID: 7045254
[TBL] [Abstract][Full Text] [Related]
11. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes.
Wright PF; Bhargava M; Johnson PR; Thompson J; Karzon DT
Vaccine; 1985 Sep; 3(3):305-8. PubMed ID: 3904259
[TBL] [Abstract][Full Text] [Related]
13. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
[TBL] [Abstract][Full Text] [Related]
15. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
Clements ML; Betts RF; Murphy BR
Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
17. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.
Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N
J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472
[TBL] [Abstract][Full Text] [Related]
18. Trivalent cold recombinant influenza live vaccine in institutionalized children with bronchial asthma and patients with psychomotor retardation.
Tanaka Y; Ueda K; Miyazaki C; Nakayama M; Kusuhara K; Okada K; Tokugawa K; Shibata R; Nishima S; Yamane N
Pediatr Infect Dis J; 1993 Jul; 12(7):600-5. PubMed ID: 8346005
[TBL] [Abstract][Full Text] [Related]
19. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children.
Gruber WC; Kirschner K; Tollefson S; Thompson J; Reed G; Edwards KM; Wright PF
J Infect Dis; 1993 Jul; 168(1):53-60. PubMed ID: 8390548
[TBL] [Abstract][Full Text] [Related]
20. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
